P8IP
HZNP

Pier 88 Investment Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Pier 88 Investment Partners’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,180
Closed -$1.06M – 103
2022
Q3 		$1.06M Buy
17,180
+6,940
+68% +$485K 0.25% 62
2022
Q2 		$816K Sell
10,240
-7,150
-41% -$677K 0.19% 72
2022
Q1 		$1.83M Sell
17,390
-673
-4% -$65.6K 0.66% 34
2021
Q4 		$1.95M Sell
18,063
-27,385
-60% -$2.99M 0.41% 58
2021
Q3 		$4.98M Buy
45,448
+16,610
+58% +$1.72M 1.49% 22
2021
Q2 		$2.7M Buy
28,838
+2,985
+12% +$275K 0.78% 30
2021
Q1 		$2.38M Sell
25,853
-5,800
-18% -$489K 0.81% 26
2020
Q4 		$2.32M Sell
31,653
-730
-2% -$54.3K 0.75% 27
2020
Q3 		$2.52M Buy
32,383
+2,502
+8% +$172K 0.76% 28
2020
Q2 		$1.66M Sell
29,881
-5,009
-14% -$214K 0.47% 57
2020
Q1 		$1.03M Buy
34,890
+22,960
+192% +$777K 0.38% 47
2019
Q4 		$432K Buy
+11,930
New +$366K 0.17% 69

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Pier 88 Investment Partners's HZNP Position: Q4 2022 in Review

Pier 88 Investment Partners sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 17,180 shares — an estimated $1.06M sold.

Pier 88 Investment Partners first reported a position in HZNP in Q4 2019 and held it in 12 quarters. The position peaked at $4.98M in Q3 2021. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

  • Pier 88 Investment Partners reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Pier 88 Investment Partners sold 17,180 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $1.06M.
  • Pier 88 Investment Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2019 and held it in 12 quarters.
  • Pier 88 Investment Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.98M in Q3 2021.
  • 615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Pier 88 Investment Partners's 13F filing for Q4 2022, filed 8 Feb 2023.